← Insider buys
ROIV

Roivant Sciences Ltd. · Healthcare

Chief Accounting Officer Rakhi Kumar sold $436K of Roivant Sciences Ltd.

Sold$435,857
$9.93Price
43,893Shares
−18%Stake

What ROIV did after the filing

Filed Jun 13Copier in Jun 14
The stock from Wed, Jun 14 open, $9.80
+19.0%
S&P 500, same days
+4.9%

Measured over 30 trading days, to the Jul 28 close.

Traded Fri, Jun 9. Filed Tue, Jun 13, 5:31 PM ET, after the close. Returns use the Jun 14 open and the Jul 28 close. Not investment advice.